SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-009771
Filing Date
2016-05-13
Accepted
2016-05-13 16:56:18
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 839965
2 ex31-1.htm EX-31.1 16769
3 ex31-2.htm EX-31.2 16803
4 ex32-1.htm EX-32.1 7455
5 ex32-2.htm EX-32.2 7610
  Complete submission text file 0001493152-16-009771.txt   6800905

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE corx-20160331.xml EX-101.INS 1159322
7 XBRL SCHEMA FILE corx-20160331.xsd EX-101.SCH 91249
8 XBRL CALCULATION FILE corx-20160331_cal.xml EX-101.CAL 48171
9 XBRL DEFINITION FILE corx-20160331_def.xml EX-101.DEF 371701
10 XBRL LABEL FILE corx-20160331_lab.xml EX-101.LAB 614015
11 XBRL PRESENTATION FILE corx-20160331_pre.xml EX-101.PRE 427448
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 161649186
SIC: 2834 Pharmaceutical Preparations